The Ki67 proliferation index is a quantitative indicator of clinical risk in mantle cell lymphoma

Mantle cell lymphoma (MCL) is a distinctive type of non-Hodgkin lymphoma (NHL) that is considered an aggressive neoplasm. The clinical course, however, is variable, with some patients living less than a year while others survive for more than 10 years.[1][1] Therefore, many attempts have been made